Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Infectious Diseases

    Automated Diagnosis of COVID-19 From Chest CTs

    By Global Biodefense StaffOctober 22, 2021
    Philip Chikontwe and Prof. Sang Hyun Park from Daegu Gyeongbuk Institute of Science and Technology (DGIST), South Korea, have developed a new framework for accurate and interpretable automated analysis of chest CT scans. Credit: DGIST
    Share
    Facebook LinkedIn Reddit Email

    Scientists develop new algorithm for rapid, computerized diagnosis of COVID-19, overcoming the limitations of reverse transcription polymerase chain reaction

    In a little over 18 months, the novel coronavirus (SARS-CoV-2) has infected over 18 million people and caused more than 690,000 deaths. The current standard for diagnosis through reverse transcription polymerase chain reaction is limited owing to its low sensitivity, high rate of false positives, and long testing times. This makes it difficult to identify infected patients quickly and provide them with treatment. Furthermore, there is a risk that patients will still spread the disease while waiting for the results of their diagnostic test.

    Chest CT scans have emerged as a quick and effective way to diagnose the disease, but they require radiologist expertise to interpret, and sometimes the scans look similar to other kinds of lung infections, like bacterial pneumonia. Now, a new paper in Medical Imaging Science by a team of scientists, including those from Daegu Gyeongbuk Institute of Science (DGIST), South Korea, details a technique for the automated and accurate interpretation of chest CT scans. “As academics who were equally affected by the COVID pandemic, we were keen to use our expertise in medical image analysis to aid in faster diagnosis and improve clinical workflows,” says Prof. Sang Hyun Park and Philip Chikontwe from DGIST, who led the study.

    The DA-CMIL algorithm is an automated framework that analyzes chest CT scans to diagnose COVID-19 rapidly and accurately, and moreover, differentiate it from other chest infections like bacterial pneumonia. Credit: Pixabay

    To build their diagnostic framework, the research team used a Machine Learning technique called “Multiple Instance Learning” (MIL). In MIL, the machine learning algorithm is “trained” using sets, or “bags,” of multiple examples called “instances.” The MIL algorithm then uses these bags to learn to label individual examples or inputs. The research team trained their new framework, called dual attention contrastive based MIL (DA-CMIL), to differentiate between COVID and bacterial pneumonia, and found that its performance was on par to other state-of-the-art automated image analysis methods. Moreover, the DA-CMIL algorithm can leverage limited or incomplete information to efficiently train its AI system.

    “Our study can be viewed from both a technical and clinical perspective. First, the algorithms introduced here can be extended to similar settings with other types of medical images. Second, the ‘dual attention,’ particularly the ‘spatial attention,’ used in the model improves the interpretability of the algorithm, which will help clinicians understand how automated solutions make decisions,” explain Prof. Park and Mr. Chikontwe.

    This research extends far beyond the COVID pandemic, laying the foundation for the development of more robust and cheap diagnostic systems, which will be of particular benefit to under-developed countries or countries with otherwise limited medical and human resources.

    Dual attention multiple instance learning with unsupervised complementary loss for COVID-19 screening. Medical Image Analysis, August 2021.

    Artificial Intelligence COVID-19 Editor Pick Mass Casualty Medicine-Health Public Health Emergency SARS-CoV-2
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiodefense Headlines – 21 October 2021
    Next Article First-Ever Malaria Vaccine Has Roots in Army Medical Research

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy